Journey Medical's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Journey Medical (NASDAQ:DERM) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.33. The company's past performance shows a pattern of beating EPS estimates but experiencing share price drops. The stock is currently trading at $2.1, down 46.5% over the last 52-week period.
August 07, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Journey Medical is expected to report an EPS of $-0.33. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is currently down 46.5% over the last 52 weeks.
Journey Medical has a history of beating EPS estimates but experiencing share price drops. Given this pattern and the current negative returns, it's likely the stock price will be negatively impacted in the short term, especially if the company fails to provide positive guidance for the next quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100